Paul Shapiro, Ph.D.
About Paul Shapiro, Ph.D.
Paul Shapiro, Ph.D., is the Scientific Associate Director and Functional Assays & Screening Team Leader at Bristol Myers Squibb, with extensive experience in high-throughput functional assays and screening for antibody therapeutics discovery.
Current Position at Bristol Myers Squibb
Paul Shapiro, Ph.D., holds the title of Scientific Associate Director, Functional Assays & Screening Team Leader (Biotherapeutics Discovery) at Bristol Myers Squibb. He is based in Redwood City, California, United States. In this role, Dr. Shapiro leads initiatives in high-throughput functional assays and screening processes aimed at the discovery of antibody therapeutics.
Previous Roles at SRI International and Eurofins DiscoverX
Before his current position, Paul Shapiro served as Program Director for Assay Biology and Automation at SRI International in Menlo Park, California, from 2022 to 2023. Prior to that, he was a Sr. Principal Scientist and Group Leader, as well as a Group Leader, in Assay and Product Development at Eurofins DiscoverX in Fremont, California. He contributed to various assay development projects during his tenure from 2016 to 2022.
Experience at Molecular Devices and SageMedic
Dr. Shapiro also worked at Molecular Devices, LLC (Danaher) as a Technical Support Specialist for 11 months in 2015. Previously, he was Scientist & Director of Assay Development and Screening at SageMedic Inc from 2013 to 2014. Throughout these roles, Dr. Shapiro enhanced his expertise in assay development and high-throughput screening technologies.
Early Career in Academia and Industry
Paul Shapiro's early career includes positions such as Principal Scientist in Molecular Genetics at Elan Pharmaceuticals and roles at Intrexon Corporation as Principal Scientist and Manager, Bioassays. He was also a Senior Scientist at Qiagen Genomics. His academic career features an Assistant Professorship at OHSU and a Postgraduate Research Neuroscientist role at UCSD, focusing on molecular biology and biochemistry.
Education and Technical Expertise
Paul Shapiro earned his Ph.D. in Physiology and Pharmacology from the University of California, San Diego, where he also completed his Bachelor of Arts in Chemistry. His extensive technical expertise spans drug discovery, development, functional genomics, target discovery, and biomarker validation. Dr. Shapiro has a robust background in leading assay development and screening teams across various sectors, including pharma, biotech, start-ups, and academia.